NMTC Stock Analysis: Buy, Sell, or Hold?
NMTC - NeuroOne Medical Technologies Corporation Common Stock
$1.12
0.13 (13.69%)
▲
5d:
-15.79%
30d:
-32.93%
90d:
-63.75%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When NMTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NMTC is down 15.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NMTC is down 15.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: NMTC is currently trading at $1.12, which is considered oversold relative to its 30-day fair value range of $1.22 to $1.73.
Technical Outlook: Technically, NMTC is in a strong downtrend. Immediate support is located at $0.96, while resistance sits at $1.42. The stock is showing strong short-term momentum, up 13.7% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $7.27 (+548.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NMTC is in a strong downtrend. Immediate support is located at $0.96, while resistance sits at $1.42. The stock is showing strong short-term momentum, up 13.7% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $7.27 (+548.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.22 -
$1.73
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+13.7%)
- BULLISH: Trading 548.8% below Wall St target ($7.27)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.22 -
$1.73
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.96
Resistance Level
$1.42
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.77
Wall Street Target
$7.27
(+548.8%)
Revenue Growth (YoY)
16.3%
Profit Margin
-59.7%
Share & Embed Analysis
Last updated: October 04, 2026 2:46 AM ET
Data refreshes hourly during market hours. Next update: 3:46 AM
Data refreshes hourly during market hours. Next update: 3:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NMTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 69 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 51 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 58 HOLD |
